Echo Lake Capital cancelled the acquisition of Quince Therapeutics, Inc..
Echo Lake Capital cancelled the acquisition of Quince Therapeutics, Inc. (NasdaqGS:QNCX) on April 11, 2023. Board of Directors unanimously rejected the unsolicited proposal it received from Echo Lake Capital to acquire Quince for $1.60 per share in cash. Following careful review and evaluation, the Quince Board concluded that Echo Lake Capitalâs proposal undervalues the company and is not in the best interest of Quince and its shareholders.